Kolon TissueGene Indicted by Prosecutors for Violation of Capital Markets Act
[Asia Economy Reporter Kim Hyemin] Kolon TissueGene announced on the 25th that "it has been confirmed that the company was indicted by the prosecution for violating the Act on Capital Markets and Financial Investment Business."
Hot Picks Today
There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- [Breaking] Trump: "I Don't Think There Is a Conflict in Taiwan... Made No Promises"
- Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
The company stated, "Whether the charges are true will be determined through future trials."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
